Headlines about Senestech (NASDAQ:SNES) have trended somewhat positive recently, Accern reports. The research group identifies positive and negative media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Senestech earned a media sentiment score of 0.10 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.7138035825207 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the media stories that may have impacted Accern’s scoring:

SNES has been the subject of several research reports. Zacks Investment Research upgraded Senestech from a “sell” rating to a “hold” rating in a research report on Thursday, July 13th. Roth Capital set a $14.00 target price on Senestech and gave the stock a “buy” rating in a research report on Saturday, May 13th.

Senestech (NASDAQ SNES) opened at 2.54 on Monday. Senestech has a 12 month low of $2.03 and a 12 month high of $10.69. The firm’s market cap is $26.23 million. The stock has a 50 day moving average price of $3.87 and a 200 day moving average price of $6.55.

Senestech (NASDAQ:SNES) last released its quarterly earnings data on Thursday, August 10th. The company reported ($0.35) earnings per share for the quarter, missing the consensus estimate of ($0.28) by $0.07. The firm had revenue of $0.01 million during the quarter, compared to the consensus estimate of $0.10 million. On average, equities analysts expect that Senestech will post ($1.30) earnings per share for the current fiscal year.

In related news, Director Julia Ann Williams acquired 9,100 shares of the stock in a transaction dated Thursday, August 17th. The shares were bought at an average cost of $2.80 per share, for a total transaction of $25,480.00. Following the purchase, the director now owns 12,050 shares in the company, valued at approximately $33,740. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Andrew Altman acquired 20,000 shares of the stock in a transaction dated Friday, August 18th. The stock was bought at an average price of $2.77 per share, for a total transaction of $55,400.00. Following the completion of the purchase, the chief operating officer now owns 2,600 shares in the company, valued at approximately $7,202. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 54,100 shares of company stock worth $155,730. Corporate insiders own 27.40% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.thecerbatgem.com/2017/08/21/senestech-snes-given-media-impact-rating-of-0-10.html.

Senestech Company Profile

SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.

Receive News & Stock Ratings for Senestech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech Inc. and related stocks with our FREE daily email newsletter.